Frequency of MET exon 14 skipping mutations in non-small cell lung cancer according to technical approach in routine diagnosis: results from a real-life cohort of 2,369 patients

BACKGROUND: Mesenchymal epithelial transition receptor (MET) alterations, including MET exon 14 skipping mutation, are oncogenic in non-small cell lung cancer (NSCLC) and may confer sensitivity to targeted therapy. Given the rarity and the diversity of exon 14 skipping mutations, diagnosis may be ch...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Thorac Dis
Prif Awduron: Champagnac, Anne, Bringuier, Pierre-Paul, Barritault, Marc, Isaac, Sylvie, Watkin, Emmanuel, Forest, Fabien, Maury, Jean-Michel, Girard, Nicolas, Brevet, Marie
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: AME Publishing Company 2020
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7330338/
https://ncbi.nlm.nih.gov/pubmed/32642122
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2020.04.21
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg